TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · no major macro event
GSK

GlaxoSmithKline PLC

Healthcare · Drug Manufacturers - General

50.50$ +0.3% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Cash Flow

GlaxoSmithKline PLC (GSK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 7,143 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow GSK
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
5,176 2,569 6,497 6,918 8,421 8,020 8,441 7,952 7,403 7,891 6,554 7,143
2,026 1,862 1,861 2,981 1,763 2,996 624 2,524 2,298 2,852 2,551 3,695
332 368 319 333 360 365 381 367 346 307 344 374
275 -93,865 161 4,127 3,171 670 380 105 -8,342
570 1,635 263 -674 -360 531 120 -473 271 -1,064 2,090 -608
1,751 1,901 2,352 2,202 1,796 2,163 2,239 2,931 2,258 1,633 2,982 1,318
-1,078 6,037 -1,269 -1,443 -1,553 -5,354 2,161 -1,777 -8,772 -2,404 -1,229 -5,723
3,843 3,874 4,850 3,906 3,927 3,953 3,977 3,999 3,467 2,793 2,444 2,508
-333 -99 -74 -65 8,774 10,284 999 -1,643 25 -197 20 -1,362
228 -24,978 130 -990 8,124 3,515 -4,234 -2,210 -4,824 -2,370 -1,166 1,506
-5,385 -7,103 -6,392 -6,380 -6,389 -1,840 -10,132 -7,589 823 -6,069 -4,726 -1,593
-1,203 1,458 -881 -1,005 487 744 431 -1,443 -394 -736 545 -206
3,425 668 4,145 4,716 6,625 5,857 6,202 5,021 5,145 6,258 3,572 5,824

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?